Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline and Naltrexone for Smoking Cessation and Drinking Reduction
NCT02698215Phase 2Completed
- Sponsor
- University of California, Los Angeles
- Start
- May 2016
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of naltrexone in nicotine dependence, alcohol use disorder (AUD), sponsored by University of California, Los Angeles. Started May 2016; status: completed.
02
Drugs
naltrexone
03
Conditions
nicotine dependencealcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT02698215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02698215.